Article info

Download PDFPDF

Phase II single arm open label multicentre clinical trial to evaluate the efficacy and side effects of a combination of gefitinib and methotrexate to treat tubal ectopic pregnancies (GEM II): study protocol

Authors

  1. Correspondence to Dr Andrew Horne; andrew.horne{at}ed.ac.uk
View Full Text

Citation

Horne AW, Skubisz MM, Doust A, et al
Phase II single arm open label multicentre clinical trial to evaluate the efficacy and side effects of a combination of gefitinib and methotrexate to treat tubal ectopic pregnancies (GEM II): study protocol

Publication history

  • Received March 18, 2013
  • Revised May 9, 2013
  • Accepted June 16, 2013
  • First published July 18, 2013.
Online issue publication 
July 18, 2013

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.